IL17A and asthma: Gaining insight into the function of Th17 cells and IL-17 in asthma has led to the exploration of targeted therapies, such as IL-17 inhibitors and other immune-modulating treatments, which may offer potential advantages for patients facing difficult-to-treat asthma phenotypes [70].